Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GSK plans $800m US manufacturing investment
Pharmaphorum
Friday, October 25, 2024 - 11:05am
tags:
GSK, drug manufacturing, Pennsylvania
GPCR drugmaker Septerna amasses $288M in IPO
BioPharma Dive
Friday, October 25, 2024 - 10:59am
tags:
Septerna, IPOs, GPCRs
Arcus' new HIF-2a data in kidney cancer hint at potential edge over Merck's Welireg, analysts say
Fierce Biotech
Thursday, October 24, 2024 - 8:27pm
tags:
Arcus Biosciences, kidney cancer, Merck, casdatifan, Welireg
Monopar retrieves Wilson disease candidate from AstraZeneca's scrap heap
Fierce Biotech
Thursday, October 24, 2024 - 8:25pm
tags:
Monopar Therapeutics, AstraZeneca, ALXN-1840, Wilson disease
Roche Inks Potential $1B Gene Therapy Deal With Dyno, Eyes Neurological Diseases
BioSpace
Thursday, October 24, 2024 - 8:21pm
tags:
Roche, gene therapy, Dyno Therapeutics, neurological disorders
How Lilly is building a brand people trust
Medical Marketing and Media
Thursday, October 24, 2024 - 8:20pm
tags:
Eli Lilly, branding, reputation, public trust
Glucose monitor maker Dexcom beats quarterly sales estimates, backs annual forecast
Reuters
Thursday, October 24, 2024 - 8:18pm
tags:
Medtech, earnings, DexCom, diabetes, CGMs
Weight-loss drugs didn't curb health costs within two years
Reuters
Thursday, October 24, 2024 - 11:11am
tags:
Novo Nordisk, Eli Lilly, Wegovy, Zepbound, obesity
Bayer, Dewpoint Therapeutics Sign Deal for Heart-Disease Treatment
Morningstar
Thursday, October 24, 2024 - 11:01am
tags:
Bayer, Dewpoint Therapeutics, heart-muscle disease
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Fierce Pharma
Thursday, October 24, 2024 - 10:58am
tags:
GSK, Arexvy, vaccines, RSV, Pfizer, FDA
Zai Lab stock rockets 24% on data for lung cancer ADC drug 39m
MSN/Seeking Alpha
Thursday, October 24, 2024 - 10:53am
tags:
Zai Lab, ZL-1310, small cell lung cancer, clinical trials, antibody-drug conjugate
Alto Neuroscience’s depression drug trial fails at phase 2
Biopharma Reporter
Thursday, October 24, 2024 - 10:50am
tags:
Alto Neuroscience, clinical trials, clinical depression, ALTO-100
Intellia links in vivo CRISPR therapy to 81% drop in HAE attacks in phase 2
Fierce Biotech
Thursday, October 24, 2024 - 9:58am
tags:
Intellia Therapeutics, CRISPR, HAE, NTLA-2002
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Reuters
Thursday, October 24, 2024 - 9:53am
tags:
Eli Lilly, Mounjaro, Novo Nordisk, Denmark, obesity
AngioDynamics launches long-term study of NanoKnife for prostate cancer
Clinical Trials Arena
Thursday, October 24, 2024 - 9:52am
tags:
AngioDynamics, prostate cancer, NanoKnife, clinical trials, medtehc
Why pharma megamergers may become a relic of the past
Pharma Voice
Thursday, October 24, 2024 - 9:49am
tags:
M&A, FTC, megamergers
Bayer partners medtech firm Impli on fertility R&D
Pharmaphorum
Thursday, October 24, 2024 - 9:48am
tags:
Bayer, Fertility, medtec, Impli
Lundbeck planning for four novel drugs in phase 3 in 2026
Pharmaphorum
Thursday, October 24, 2024 - 9:47am
tags:
Lundbeck, R&D, new molecular entity, epilepsy
In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines
Fierce Pharma
Wednesday, October 23, 2024 - 10:35pm
tags:
Pfizer, Merck, pneumococcal disease, CDC, vaccines
Thermo Fisher Q3 Earnings Top Estimates, Revenues Miss, Stock Dips
Yahoo/Zacks.com
Wednesday, October 23, 2024 - 10:33pm
tags:
Medtech, earnings, Thermo Fisher

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.